Gary McAuliffe to New Zealand
This is a "connection" page, showing publications Gary McAuliffe has written about New Zealand.
Connection Strength
1.367
-
COVID-19 serology: use and interpretation in New Zealand. N Z Med J. 2021 07 09; 134(1537):144-147.
Score: 0.135
-
COVID-19 serology: use and interpretation in New Zealand. N Z Med J. 2021 07 09; 134(1538):144-147.
Score: 0.135
-
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study. Pathology. 2021 Jun; 53(4):530-535.
Score: 0.133
-
Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand. J Virol Methods. 2021 03; 289:114042.
Score: 0.130
-
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand. N Z Med J. 2020 11 20; 133(1525):127-131.
Score: 0.130
-
International normalised ratio monitoring in the community populations of the Auckland and Northland regions of New Zealand: time in therapeutic range and frequency of testing. Intern Med J. 2018 Dec; 48(12):1487-1491.
Score: 0.113
-
Suboptimal performance of rotavirus testing in a vaccinated community population should prompt laboratories to review their rotavirus testing algorithms in response to changes in disease prevalence. Diagn Microbiol Infect Dis. 2019 Mar; 93(3):203-207.
Score: 0.112
-
Keeping track of antimicrobial resistance for Neisseria gonorrhoeae in Auckland, New Zealand: past, present and future considerations. N Z Med J. 2018 06 22; 131(1477):71-77.
Score: 0.110
-
Diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium: an observational study of testing patterns, prevalence and co-infection rates in northern New Zealand. Sex Health. 2018 06; 15(3):232-237.
Score: 0.109
-
Rotavirus Infection in the Auckland Region After the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalizations and Laboratory Implications. Pediatr Infect Dis J. 2018 Jan; 37(1):e1-e5.
Score: 0.106
-
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020. Pathology. 2021 Aug; 53(5):645-651.
Score: 0.034
-
An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory. N Z Med J. 2020 07 31; 133(1519):81-88.
Score: 0.032
-
Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand. N Z Med J. 2020 07 31; 133(1519):89-94.
Score: 0.032
-
Politicians: please work together to minimise the spread of COVID-19. N Z Med J. 2020 03 13; 133(1511):7-8.
Score: 0.031
-
Audit of Trichomonas vaginalis test requesting by community referrers after a change from culture to molecular testing, including a cost analysis. N Z Med J. 2017 Jun 16; 130(1457):34-37.
Score: 0.026